Further work to understand the mechanism whereby PGE2 may stimulate Ca2+-activated Cl- channels and MCC in CF, may help identify new therapeutic targets that may assist in the normalization of airway ion transport and clearance of pulmonary microbial insults. The gene discussed is MCC; the disease is cystic fibrosis.